Humacyte, Inc. (HUMA) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Boeing free cash flow beats estimates despite production challenges
Tweet
Share
E-mailGet Alerts HUMA Hot Sheet
Join SI Premium – FREE
Humacyte, Inc. (NASDAQ: HUMA) reported Q1 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $2.09 million.
For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning shares rise 3% in premarket trade after Q3 EPS, revenue beat estimates
- Freeport beats Q3 estimates on higher copper, gold prices
- Camden National (CAC) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
